UOC
MGNX icon

UBS O'Connor’s MacroGenics MGNX Stock Holding History

UBS O'Connor’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-70,000
Closed -$1.5M – 498
2015
Q3 		$1.5M Buy
+70,000
New +$2.2M 0.01% 407

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

UBS O'Connor's MGNX Position: Q4 2015 in Review

UBS O'Connor sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 70,000 shares — an estimated $1.5M sold.

UBS O'Connor first reported a position in MGNX in Q3 2015 and held it in 1 quarter. The position peaked at $1.5M in Q3 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

  • UBS O'Connor reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
  • UBS O'Connor sold 70,000 MacroGenics shares in Q4 2015, an estimated $1.5M.
  • UBS O'Connor first reported a position in MacroGenics in Q3 2015 and held it in 1 quarter.
  • UBS O'Connor's MacroGenics position peaked at $1.5M in Q3 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on UBS O'Connor's 13F filing for Q4 2015, filed 10 Feb 2016.